GSK research aims to unlock P-med sales
GlaxoSmithKline (GSK) has unveiled new research to help pharmacists “unlock behind-the-counter sales".
GSK said the research has revealed opportunities to accelerate the growth of the pharmacy-only section of the market through “optimising the back wall”.
Paul Griffith, senior manager, global shopper insights at GSK, said prescriptions are a “driving factor” for shoppers to visit the pharmacy, which highlights a “key opportunity” to secure unplanned purchases.
“We suggest clear signage and in-store communications to encourage shoppers to speak to the pharmacist about their needs,” Mr Griffith said.
He also recommended merchandising the back wall in a way that mirrors the healthcare aisle. "For example, showing clear sub-categories and featuring seasonal products," Mr Griffith added.
The 'back wall project' is part of GSK’s ‘Pharmacy of the Future’ initiative.
For more information, contact your local GSK sales representative.